bms INNOVATION IN BLOODCARE TECHNOLOGIES


News Detail

bms Selected as 2025 East Lake High-Tech Zone "Golden Seed" Listed Enterprise

Issuing time:2025-12-19 17:00Author:Lisa /  AdenSource:bms Medicaltech Co.,LTD

资源 5.png

This week, the Wuhan East Lake High-Tech Development Zone announced its 2025 list of "Golden Seed" enterprises—companies being groomed for public listing. bms, emerging as a dark horse in its niche sector, earned its place on this prestigious list through its core strengths in innovation, product quality, and customer service.

The "Golden Seed" title represents not only an honor but also a greater responsibility; it is both an affirmation and a catalyst for further progress. It marks a significant milestone and a new starting point for the company. After over a decade of dedicated development and refinement, bms has consistently evolved with the times, integrating innovation to secure successive breakthroughs in international markets, thereby achieving a global footprint in sales and distribution.

Moving forward, bms will leverage this recognition as an impetus to capitalize on favorable policies, accelerate R&D and market expansion, and advance its listing preparations. In collaboration with premium partners worldwide and guided by market demand, bms aims to lead the bloodcare industry into a new "Era of Chinese Innovation" through its forward-thinking technological strategy and sustained innovative capability, writing a new chapter in high-quality development.

Share to:
Contact us
 
 

  +86 177 7142 0109

   ————————

  +86 187 7111 8831